ABSTRACT. The functional polymorphism Ser326Cys (rs1052133) in the human 8-oxoguanine DNA glycosylase (hOGG1) gene has been implicated in bladder cancer risk. However, reports of this association between the Ser326Cys polymorphism and bladder cancer risk are conflicting. In order to help clarify this relationship, we made a meta-analysis of seven case-control studies, summing 2521 cases and 2408 controls. We used odds ratios (ORs) with 95% confidence intervals (95%CIs) to assess the strength of the association. Overall, no significant association between the hOGG1 Ser326Cys polymorphism and bladder cancer risk was found for Cys/Cys vs Ser/Ser (OR = 1.10, 95%CI = 0.74-1.65), Ser/Cys vs Ser/Ser (OR = 1.07, 95%CI = 0.81-1.42), Cys/Cys + Ser/Cys vs Ser/Ser (OR = 1.08, 95%CI = 0.87-1.33), and Cys/Cys vs Ser/Cys + Ser/Ser (OR = 1.04, 95%CI = 0.65-1.69). Even when stratified by ethnicity, no significant association was ©FUNPEC-RP www.funpecrp.com.br Genetics and Molecular Research 11 (3): 3490-3496 (2012) hOGG1 polymorphism and bladder cancer risk 3491
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INTRODUCTION
Bladder cancer ranks ninth in worldwide cancer incidence and is more frequent in men than in women (Murta-Nascimento et al., 2007) . The incidence of bladder cancer varies considerably between countries, with the highest incidence rates seen in Western countries and the lowest rates in Asian countries (Kakehi et al., 2010) . Researchers have reached a consensus that bladder cancer is an excellent model for studying genetic susceptibility and geneenvironment interaction in cancer etiology. Cigarette smoking and occupational exposure to carcinogens are believed to play a critical role in the incidence of bladder cancer (Zeegers et al., 2000; Reulen et al., 2008; Wu et al., 2008) . Nevertheless, only a small percentage of individuals with environmental exposure develop bladder cancer, suggesting a genetic contribution to bladder cancer etiology.
DNA damage, which is associated with carcinogenesis, can be removed or repaired through different repair systems. The base excision repair pathway, which is composed of many DNA repair genes, mainly removes DNA damage caused by ionizing radiation and reactive oxidative species (ROS; Yuan et al., 2010) . The human 8-oxoguanine DNA glycosylase (hOGG1) gene, as a component of the base excision repair pathway, performs the initial step of recognizing the 8-hydroxyguanine damage, which is highly mutagenic and a major form of oxidative DNA damage (Yun et al., 2012) . Researchers have found a number of hOGG1 functional polymorphisms such as Arg46Gln, Arg154His, Ser326Cys, Gly308Glu, and Arg229Gln (Blons et al., 1999; Audebert et al., 2000; Hill and Evans, 2007) . In recent years, the common functional polymorphism (Ser326Cys) has been investigated in many studies. The C/G polymorphism at 1245 bp (C1245G) in exon 7 of the hOGG1 gene results in an amino acid substitution of serine (Ser) with cysteine (Cys) at codon 326 (Ser326Cys, rs1052133) (Zhang et al., 2011) . A functional study showed that the 326Cys allele had reduced DNA repair activity (Kohno et al., 1998) and was associated with cancer risk (Weiss et al., 2005) . To date, many studies have assessed the association between the hOGG1 Ser326Cys polymorphism and bladder cancer risk, which have shown inconclusive results (Figueroa et al., 2007; Arizono et al., 2008; Narter et al., 2009; Gangwar et al., 2009) . In search of a conclusive association, we carried out a meta-analysis of seven published case-control studies to comprehensively evaluate the role of the hOGG1 Ser326Cys polymorphism in the susceptibility to bladder cancer.
MATERIAL AND METHODS

Eligible studies and data extraction
The PubMed database was searched using combinations of the following phrases: "hOGG1/ OGG1/OGG/human 8-oxoguanine DNA glycosylase", "polymorphism", and "bladder cancer" (last search on July 20, 2011). To retrieve the most eligible studies, we evaluated all associated articles and their references, which were hand-searched. The inclusion criteria were: 1) English-language articles, 2) case-control studies, 3) evaluation of the Ser326Cys polymorphism and bladder cancer risk, and 4) to contain useful genotype frequency. For each of the eligible publications, the following data was extracted: first author's surname, year of publication, country of study population, ethnicity, total number of cases and controls, genotyping methods, and matching criteria.
Statistical analysis
For the control group of each study, the allelic frequency was calculated, and the observed genotype frequencies of the hOGG1 Ser326Cys polymorphism were assessed for Hardy-Weinberg equilibrium (HWE) using the chi-square test. The effect measure of choice was odds ratio (OR) with its corresponding 95% confidence interval (95%CI) and the Z-test was used to determine the significance of the summary OR, with P < 0.05 considered to be statistically significant. The heterogeneity between studies was tested by the Q-statistic (Zintzaras and Ioannidis, 2005) . If P < 0.10 was considered significant for heterogeneity between studies, the summary OR estimate of each study was calculated by the randomeffect model (the DerSimonian and Laird method). Otherwise, fixed-effect models (MantelHaenszel) were used (Lau et al., 1997) .
The genotype frequencies of the hOGG1 Ser326Cys polymorphism were examined using heterozygote comparison (Ser/Cys vs Ser/Ser), homozygote comparison (Cys/Cys vs Ser/Ser), dominant model (Ser/Cys + Cys/Cys vs Ser/Ser), and recessive model (Cys/Cys vs Ser/Cys + Ser/Ser). Funnel plots and the Egger linear regression test were used to determine potential publication bias (Egger et al., 1997) . All analyses were done with the Stata software (version 10.0; StataCorp LP, College Station, TX, USA), and all tests were two-sided.
RESULTS
Characteristics of studies
There were 284 published articles relevant to the search words and manual search. Figure 1 showed the process of inclusion and exclusion of associated studies. Finally, a total of 7 articles including 2521 cases and 2408 controls were selected in our meta-analysis (Kim et al., 2005; Wu et al., 2006; Karahalil et al., 2006; Figueroa et al., 2007; Arizono et al., 2008; Narter et al., 2009; Gangwar et al., 2009) . The characteristics of the eligible studies are summarized in Table 1 . Seven independent studies consisted of 3 Asian and 4 European. A classic polymerase chain reaction-restriction fragment length polymorphism assay was conducted in 5 of the 7 studies. The other two studies used the TaqMan method to detect the genotypes. Bladder cancer was confirmed histologically or pathologically in most studies. In addition, the controls were all hospital-based and mainly matched on age and gender. The distribution of genotypes among the controls of the studies was in agreement with HWE for all except two studies (Karahalil et al., 2006; Narter et al., 2009 ).
Quantitative synthesis
In the present study, we did not observe any significant association between the hOGG1 Ser326Cys polymorphism and bladder cancer risk. The results showed that individuals carrying the Cys/Cys genotype did not have an increased bladder cancer risk compared to the Ser/Ser genotype (OR = 1.10, 95%CI = 0.74-1.65); similarly, no significant association was found in the recessive genetic model (OR = 1.04, 95%CI = 0.65-1.69), and dominant genetic model (OR = 1.08, 95%CI = 0.87-1.33) ( Table 2 ). In the stratified analysis by ethnicity, significant results were still not observed in any of the genetic models (Table 2) . Excluding the two articles that were not in HWE (P < 0.05), we saw that the results were similar (data not shown). 
Publication bias
Funnel plots and the Egger test showed no evidence of publication bias in any comparison model (P > 0.05).
DISCUSSION
ROS may be generated as a by-product of normal cellular metabolism as well as by exposure to exogenous compounds (Weiss et al., 2005) . ROS may cause oxidative DNA damage and increase susceptibility to bladder cancer if they are not removed. 8-OHdG is a highly mutagenic base produced in DNA as a result of exposure to ROS and it can be excised by hOGG1 (Weiss et al., 2005) . The hOGG1 Ser326Cys polymorphism has been shown to be associated with hOGG1 activity. Functional studies have shown that suppression of spontaneous mutagenesis is significantly lower for hOGG1 Cys326 than Ser326 (Kohno et al., 1998) . Moreover, Tarng et al. (2001) and Chen et al. (2003) found that 8-OHdG levels were significantly higher among patients with the Cys/Cys genotype compared to other genotypes. OGG1 mutant mice exhibit a relatively higher level of 8-oxoguanine and an increase in mutation frequency during the cell cycle (Luna et al., 2005) . A number of studies have shown that Cys/Cys increases bladder cancer risk (Karahalil et al., 2006; Arizono et al., 2008; Gangwar et al., 2009 ), a finding contrary to the results obtained by Kim et al. (2005) . Meanwhile, several other studies have indicated that there is no association between the hOGG1 Ser326Cys polymorphism and bladder cancer risk (Wu et al., 2006; Figueroa et al., 2007; Narter et al., 2009 ). Meta-analysis, which is a powerful statistical method, can provide a quantitative approach for pooling the results of different investigations on the same topic, estimating and explaining their diversity (Ioannidis et al., 2001; Munafo, 2004) . Thus, we conducted the present meta-analysis to evaluate the association between the hOGG1 Ser326Cys polymorphism and bladder cancer risk. We found no statistical evidence of an overall effect of the Ser326Cys polymorphism on bladder cancer risk in all the genetic models. The results may come from chance because studies with small sample sizes may be underpowered to detect a slight effect or may have generated a fluctuating risk estimate.
Lifestyle and genetic susceptibility are both important risk factors for the development of bladder cancer (Kakehi et al., 2010) . Thus, subanalysis with regard to different ethnicity was performed. However, the results showed no difference between the European population and Asian population, which may suggest that those ethnic differences in genetic backgrounds and the environmental/life style context do not play a crucial role in the associa- Table 2 . Stratified analysis of the hOGG1 Ser326Cys polymorphism and bladder cancer risk.
The P value was evaluated by the Q-test for heterogeneity. *The random-effect model was used when the P value for heterogeneity <0.10; otherwise, the fixed-effect model was used. OR = odds ratio; 95%CI = confidence interval.
tion of the hOGG1 Ser326Cys polymorphism with bladder cancer risk. Moreover, significant between-study heterogeneity was still detected in both populations in stratified analyses by ethnicity, and we conducted analyses using random-effect models. Thus, we obtained a wider confidence interval and a larger P value, which may have distorted the result.
There are still some limitations in this meta-analysis. First, selection bias could have played a role because the genotype distribution of this polymorphism among control subjects deviated from HWE in two studies (Karahalil et al., 2006; Narter et al., 2009 ) and all of the controls were hospital-based, which may not be representative of the general population. Second, the number of cases and controls in the included studies was relatively low (data shown in Table 1 ). Third, lack of information on well-documented smoking status may influence the results because cigarette smoking is an established risk factor for bladder cancer (Moss, 1971) , which may interact with the hOGG1 Ser326Cys polymorphism on bladder cancer risk (Huang et al., 2007) . Finally, the fact that studies included in the analysis used different genotyping methods that had different quality control issues may have also influenced the results. Therefore, the results of this study should be interpreted with caution.
In conclusion, our results suggest that the hOGG1 Ser326Cys polymorphism is not associated with bladder cancer risk. Well-designed studies with larger sample size are needed to validate these findings.
